Endocrine disorders occur when glands produce too much or too little hormones disrupting the balance needed for the body to ...

13, 2024 — Babies born to pregnant women with obesity are more likely to develop heart problems and diabetes as adults ... in mice sheds light on how thyroid hormone alters wiring in the brain.

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease ... with type 2 diabetes using a GLP-1 drug have a similar risk for thyroid cancer as those ...

Hypothyroidism, a condition characterized by insufficient production of thyroid hormones, affects millions of people worldwide, often requiring lifelong daily hormone replacement therapy. Sernova’s ...

The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, ...

If the thyroid gland functions slowly, it leads to hypothyroidism. During this period, cold sensitivity, weight gain, and a ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

The hypothalamic–pituitary–thyroid axis plays a crucial role in the pathogenesis, diagnosis, risk stratification, effectiveness of radioiodine therapy, and treatment response evaluation in epithelial ...

Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney ...

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...